Adage Capital Partners’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-18,620
Closed -$229K – 907
2023
Q3
$229K Sell
18,620
-181,380
-91% -$2.7M ﹤0.01% 795
2023
Q2
$3.21M Sell
200,000
-100,000
-33% -$1.65M 0.01% 713
2023
Q1
$5.22M Buy
+300,000
New +$4.27M 0.01% 703

Other funds holding NEO

Adage Capital Partners's NEO Position: Q4 2023 in Review

Adage Capital Partners sold out of NeoGenomics (NEO) in Q4 2023, closing a stake of 18,620 shares — an estimated $229K sold.

Adage Capital Partners first reported a position in NEO in Q1 2023 and held it in 3 quarters. The position peaked at $5.22M in Q1 2023. 287 funds tracked by Wall St. Rank hold NEO as of Q4 2023.

  • Adage Capital Partners reported no remaining NeoGenomics position as of Q4 2023 after selling out during the quarter.
  • Adage Capital Partners sold 18,620 NeoGenomics shares in Q4 2023, an estimated $229K.
  • Adage Capital Partners first reported a position in NeoGenomics in Q1 2023 and held it in 3 quarters.
  • Adage Capital Partners's NeoGenomics position peaked at $5.22M in Q1 2023.
  • 287 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2023.

Based on Adage Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.